131 related articles for article (PubMed ID: 26909298)
1. Bone metastases in breast cancer: Frequency, metastatic pattern and non-systemic locoregional therapy.
Steinauer K; Huang DJ; Eppenberger-Castori S; Amann E; Güth U
J Bone Oncol; 2014 May; 3(2):54-60. PubMed ID: 26909298
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy in patients with distant metastatic breast cancer.
Steinauer K; Gross MW; Huang DJ; Eppenberger-Castori S; Güth U
Radiat Oncol; 2014 May; 9():126. PubMed ID: 24885766
[TBL] [Abstract][Full Text] [Related]
3. Disease-related surgery in patients with distant metastatic breast cancer.
Amann E; Huang DJ; Weber WP; Eppenberger-Castori S; Schmid SM; Hess TH; Güth U
Eur J Surg Oncol; 2013 Nov; 39(11):1192-8. PubMed ID: 24029666
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of breast cancer patients with brain metastasis treated with radiotherapy.
Simonsen MK; Vrou Offersen B; Jensen AB
Acta Oncol; 2023 Aug; 62(8):871-879. PubMed ID: 37498539
[TBL] [Abstract][Full Text] [Related]
5. Role of whole brain radiotherapy in the management of infratentorial metastases from lung and breast cancer.
Cacho-Díaz B; Alvarez-Alvarez A; Salmerón-Moreno K; Rodríguez-Mayoral O; Santiago-Concha BG; Arrieta Rodríguez OG
Rep Pract Oncol Radiother; 2021; 26(4):512-517. PubMed ID: 34434566
[TBL] [Abstract][Full Text] [Related]
6. Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype.
Arvold ND; Oh KS; Niemierko A; Taghian AG; Lin NU; Abi-Raad RF; Sreedhara M; Harris JR; Alexander BM
Breast Cancer Res Treat; 2012 Nov; 136(1):153-60. PubMed ID: 22968656
[TBL] [Abstract][Full Text] [Related]
7. Utilization of palliative radiotherapy for breast cancer patients with bone metastases treated with bisphosphonates-Toronto Sunnybrook Regional Cancer Centre experience.
Enright K; Clemons M; Chow E
Support Care Cancer; 2004 Jan; 12(1):48-52. PubMed ID: 14577020
[TBL] [Abstract][Full Text] [Related]
8. Outcome and clinico-biological characteristics of advanced breast cancer patients with surgically resected brain metastases: a multidisciplinary approach.
Munzone E; Casali C; Aurilio G; Botteri E; Perin A; Pelicci G; Brescia P; Sciandivasci A; Adamoli L; Viale G; Dimeco F
Ecancermedicalscience; 2013; 7():309. PubMed ID: 23634179
[TBL] [Abstract][Full Text] [Related]
9. Impact of intense systemic therapy and improved survival on the use of palliative radiotherapy in patients with bone metastases from prostate cancer.
Nieder C; Haukland E; Mannsåker B; Norum J
Oncol Lett; 2016 Oct; 12(4):2930-2935. PubMed ID: 27698881
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy for patients with unresected locally advanced breast cancer.
Yee C; Alayed Y; Drost L; Karam I; Vesprini D; McCann C; Soliman H; Zhang L; Chow E; Chan S; Lee J
Ann Palliat Med; 2018 Oct; 7(4):373-384. PubMed ID: 30180725
[TBL] [Abstract][Full Text] [Related]
11. Primary and secondary distant metastatic breast cancer: two sides of the same coin.
Güth U; Magaton I; Huang DJ; Fisher R; Schötzau A; Vetter M
Breast; 2014 Feb; 23(1):26-32. PubMed ID: 24215983
[TBL] [Abstract][Full Text] [Related]
12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
13. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy for palliation of symptoms in incurable cancer.
Hoegler D
Curr Probl Cancer; 1997; 21(3):129-83. PubMed ID: 9202888
[TBL] [Abstract][Full Text] [Related]
15. Survival After Palliative Radiotherapy in Patients with Breast Cancer and Bone-only Metastases.
Nieder C; Dalhaug A; Pawinski A; Mannsåker B; Haukland E
In Vivo; 2016 11-12; 30(6):879-883. PubMed ID: 27815475
[TBL] [Abstract][Full Text] [Related]
16. Disseminated tumor cells and the risk of locoregional recurrence in nonmetastatic breast cancer.
Bidard FC; Kirova YM; Vincent-Salomon A; Alran S; de Rycke Y; Sigal-Zafrani B; Sastre-Garau X; Mignot L; Fourquet A; Pierga JY
Ann Oncol; 2009 Nov; 20(11):1836-41. PubMed ID: 19556319
[TBL] [Abstract][Full Text] [Related]
17. Pattern of dissemination and survival following isolated locoregional recurrence of breast cancer. A prospective study with more than 10 years of follow up.
Kamby C; Sengeløv L
Breast Cancer Res Treat; 1997 Sep; 45(2):181-92. PubMed ID: 9342443
[TBL] [Abstract][Full Text] [Related]
18. The incidence and clinical impact of bone metastases in non-small cell lung cancer.
Kuchuk M; Kuchuk I; Sabri E; Hutton B; Clemons M; Wheatley-Price P
Lung Cancer; 2015 Aug; 89(2):197-202. PubMed ID: 26003503
[TBL] [Abstract][Full Text] [Related]
19. Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.
Adewuyi SA; Mbibu NH; Samaila MO; Ketiku KK; Durosinmi-Etti FA
Niger Postgrad Med J; 2013 Mar; 20(1):45-51. PubMed ID: 23661210
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection-Outcome, Prognostic Factors, and Recurrence Patterns.
El Shafie RA; Dresel T; Weber D; Schmitt D; Lang K; König L; Höne S; Forster T; von Nettelbladt B; Eichkorn T; Adeberg S; Debus J; Rieken S; Bernhardt D
Front Oncol; 2020; 10():693. PubMed ID: 32477942
[No Abstract] [Full Text] [Related]
[Next] [New Search]
